Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

V Boldescu, MAM Behnam, N Vasilakis… - Nature Reviews Drug …, 2017 - nature.com
Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging
Zika virus, are an increasing and probably lasting global risk. This Review summarizes and …

[HTML][HTML] Recent advances in antiviral drug development towards dengue virus

B Troost, JM Smit - Current opinion in virology, 2020 - Elsevier
Highlights•Evaluating drug efficacy, specificity and toxicity may help to develop an optimal
treatment regime for in vivo studies.•Measuring time to resolve viremia in vivo may help to …

Iminosugars past, present and future: medicines for tomorrow

G Horne, FX Wilson, J Tinsley, DH Williams… - Drug discovery today, 2011 - Elsevier
Iminosugars comprise the most attractive class of carbohydrate mimetics reported to date
and are ideally positioned to take advantage of our increasing understanding of …

Flavivirus NS1 and its potential in vaccine development

KL Carpio, ADT Barrett - Vaccines, 2021 - mdpi.com
The Flavivirus genus contains many important human pathogens, including dengue,
Japanese encephalitis (JE), tick-borne encephalitis (TBE), West Nile (WN), yellow fever (YF) …

The medicinal chemistry of dengue virus

MAM Behnam, C Nitsche, V Boldescu… - Journal of medicinal …, 2016 - ACS Publications
The dengue virus and related flaviviruses are an increasing global health threat. In this
perspective, we comment on and review medicinal chemistry efforts aimed at the prevention …

The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design

D Watterson, N Modhiran, PR Young - Antiviral research, 2016 - Elsevier
The flavivirus non-structural protein, NS1, is an unusual viral gene product. Despite the
recent unveiling of its atomic structure (Akey et al., 2014), and a growing list of host …

Flaviviral NS4b, chameleon and jack‐in‐the‐box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention

J Zmurko, J Neyts, K Dallmeier - Reviews in medical virology, 2015 - Wiley Online Library
Dengue virus and other flaviviruses such as the yellow fever, West Nile, and Japanese
encephalitis viruses are emerging vector‐borne human pathogens that affect annually more …

Revisiting dengue virus–host cell interaction: new insights into molecular and cellular virology

EG Acosta, A Kumar, R Bartenschlager - Advances in virus research, 2014 - Elsevier
Dengue virus (DENV) is an emerging mosquito-borne human pathogen that affects millions
of individuals each year by causing severe and potentially fatal syndromes. Despite intense …

U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication

MK Poh, G Shui, X Xie, PY Shi, MR Wenk, F Gu - Antiviral research, 2012 - Elsevier
The level of cholesterol in host cells has been shown to affect viral infection. However, it is
still not understood why this level of regulation is important for successful infection. We have …

Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions

J Chang, TM Block, JT Guo - Antiviral research, 2013 - Elsevier
Endoplasmic reticulum (ER)-resident α-glucosidases I and II sequentially trim the three
terminal glucose moieties on N-linked glycans attached to nascent glycoproteins. These …